Chicago City Guide

Horizon Bancorp Announces Definitive Agreement to Acquire Indiana-Based Heartland Bancshares, Inc.

MICHIGAN CITY, Ind.–(BUSINESS WIRE)–Horizon Bancorp (NASDAQ: HBNC), an Indiana headquartered community bank holding company, announced today that it entered into a definitive agreement to acquire Heartland Bancshares, Inc. (OTCBB: HRTB) and its wholly-owned subsidiary, Heartland Community Bank, based in Franklin, Indiana. Under the terms of the merger agreement, Horizon has agreed to issue 0.54 shares (subject to adjustment) of its common stock for each share of Heartland common stock outstand

Here is the original post:
Horizon Bancorp Announces Definitive Agreement to Acquire Indiana-Based Heartland Bancshares, Inc.

Horizon Bancorp Announces Definitive Agreement to Acquire Indiana-Based Heartland Bancshares, Inc.

MICHIGAN CITY, Ind.–(BUSINESS WIRE)–Horizon Bancorp (NASDAQ: HBNC), an Indiana headquartered community bank holding company, announced today that it entered into a definitive agreement to acquire Heartland Bancshares, Inc. (OTCBB: HRTB) and its wholly-owned subsidiary, Heartland Community Bank, based in Franklin, Indiana. Under the terms of the merger agreement, Horizon has agreed to issue 0.54 shares (subject to adjustment) of its common stock for each share of Heartland common stock outstand

More here:
Horizon Bancorp Announces Definitive Agreement to Acquire Indiana-Based Heartland Bancshares, Inc.

APP Pharmaceuticals Announces Launch of Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP

SCHAUMBURG, Ill.–(BUSINESS WIRE)–APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States.

See the rest here:
APP Pharmaceuticals Announces Launch of Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP

APP Pharmaceuticals Announces Launch of Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP

SCHAUMBURG, Ill.–(BUSINESS WIRE)–APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States.

Read the original:
APP Pharmaceuticals Announces Launch of Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP

Rubicon Will Report Fourth Quarter Results on February 23, 2012

BENSENVILLE, Ill.–(BUSINESS WIRE)–Earnings Call Date Announcement for RBCN

Here is the original post:
Rubicon Will Report Fourth Quarter Results on February 23, 2012

Rubicon Will Report Fourth Quarter Results on February 23, 2012

BENSENVILLE, Ill.–(BUSINESS WIRE)–Earnings Call Date Announcement for RBCN

Read more here:
Rubicon Will Report Fourth Quarter Results on February 23, 2012

CF Industries Holdings, Inc. Announces Updated Start Time for Fourth Quarter and Full Year 2011 Conference Call

DEERFIELD, Ill.–(BUSINESS WIRE)–CF Industries Holdings, Inc. (NYSE: CF) today announced an update to its previously announced conference call to discuss fourth quarter and full year 2011 results. The company now plans to host the conference call to discuss these results at 9:00 a.m. ET on Thursday, February 16, 2012. The results will be released after the market closes on Wednesday, February 15, 2012. Investors can access the call by dialing 800-299-0148 or 617-801-9711. The passcode is 145900

Read more:
CF Industries Holdings, Inc. Announces Updated Start Time for Fourth Quarter and Full Year 2011 Conference Call

CF Industries Holdings, Inc. Announces Updated Start Time for Fourth Quarter and Full Year 2011 Conference Call

DEERFIELD, Ill.–(BUSINESS WIRE)–CF Industries Holdings, Inc. (NYSE: CF) today announced an update to its previously announced conference call to discuss fourth quarter and full year 2011 results. The company now plans to host the conference call to discuss these results at 9:00 a.m. ET on Thursday, February 16, 2012. The results will be released after the market closes on Wednesday, February 15, 2012. Investors can access the call by dialing 800-299-0148 or 617-801-9711. The passcode is 145900

View post:
CF Industries Holdings, Inc. Announces Updated Start Time for Fourth Quarter and Full Year 2011 Conference Call

Lucky Peterson Appearing in Chicago

When one hears the name Lucky Peterson , one may think that it’s a familiar blues name.

See original here:
Lucky Peterson Appearing in Chicago

Lucky Peterson Appearing in Chicago

When one hears the name Lucky Peterson , one may think that it’s a familiar blues name.

Follow this link:
Lucky Peterson Appearing in Chicago

Next Page »